☆ 4.8 Article

Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients

FRONTIERS IN IMMUNOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Surgery

Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic

Tomas Reischig et al.

Summary: This study found that the protection of SARS-CoV-2 mRNA vaccination against COVID-19 is limited in kidney transplant recipients, with some patients developing COVID-19 after vaccination having lower levels of anti-spike protein IgG. While some patients were able to produce higher IgG levels after COVID-19, overall humoral responses were not significant, leading to suboptimal efficacy post-vaccination.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

News Item Medicine, General & Internal

Nature does things well

[Anonymous]

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)

Add to Collection

Article Multidisciplinary Sciences

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni et al.

Summary: The Omicron variant of SARS-CoV-2 has raised concerns due to its 37 amino acid substitutions in the spike protein, particularly in the receptor-binding domain (RBD), leading to increased binding affinity with human ACE2. Neutralizing activity against Omicron was greatly reduced in convalescent and vaccinated individuals compared to the ancestral virus, but this decrease was less significant after a third vaccine dose. Broadly neutralizing monoclonal antibodies recognizing conserved RBD epitopes may be crucial in combating the Omicron variant and future zoonotic transmissions.

NATURE (2022)

Add to Collection

Article Multidisciplinary Sciences

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Lihong Liu et al.

Summary: The B.1.1.529/Omicron variant of SARS-CoV-2, initially detected in southern Africa, has rapidly spread globally and is expected to become dominant due to its enhanced transmissibility in the coming weeks. This variant poses a threat to the efficacy of current COVID-19 vaccines and antibody therapies due to its significant antibody resistance. Even individuals who have received vaccines and booster doses may have reduced neutralizing activity against B.1.1.529.

NATURE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

Laura A. VanBlargan et al.

Summary: The emergence of the B.1.1.529 Omicron variant raises concerns about the efficacy of antibody countermeasures. This study shows that some of the antibodies currently in clinical use may lose their ability to neutralize the Omicron variant.

NATURE MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

Nick Andrews et al.

Summary: A study conducted in England showed that vaccines against SARS-CoV-2 provide high protection against hospitalization and death from Covid-19 at 20 weeks or more after vaccination. However, the effectiveness of the vaccines decreases over time, especially in individuals aged 65 and older and those with underlying risk factors.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients A Randomized Clinical Trial

Roman Reindl-Schwaighofer et al.

Summary: Less than 50% of kidney transplant recipients developed antibodies against the SARS-CoV-2 spike protein after 2 doses of an mRNA vaccine. A third dose of either mRNA or vector vaccine increased antibody response in 39% of KTRs without prior immune response, but neutralizing antibodies and T-cell response remained low. Triple immunosuppression, longer time after transplant, and torque teno virus plasma levels were associated with vaccine response. Local pain was higher with mRNA vaccine, but systemic symptoms were similar between groups.

JAMA INTERNAL MEDICINE (2022)

Add to Collection

Article Surgery

Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients

Marta Kantauskaite et al.

Summary: Kidney transplant recipients (KTRs) have a weaker immune response to SARS-CoV-2 vaccination compared to controls, with mycophenolate mofetil (MMF) treatment being the strongest predictor for impaired response. Adjusting MMF dose may improve the immune response in KTRs.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Add to Collection

Letter Urology & Nephrology

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

Ilies Benotmane et al.

KIDNEY INTERNATIONAL (2022)

Add to Collection

Article Transplantation

MO184: Development and Validation of a Multivariable Prediction Model for Nonseroconversion after SARS-COV-2 Vaccination in Kidney Transplant Recipients

Sophie Frölke et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Add to Collection

Article Multidisciplinary Sciences

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

Matthew McCallum et al.

Summary: The SARS-CoV-2 Omicron variant evades antibody-mediated immunity and exhibits enhanced affinity for host cells due to accumulation of spike mutations and remodeling of interactions with the ACE2 receptor.

SCIENCE (2022)

Add to Collection

Article Medicine, General & Internal

Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months

Guruprasad R. Medigeshi et al.

Summary: This cross-sectional study found a significant reduction in the neutralising ability of both vaccine-induced and vaccine plus infection induced antibodies against the omicron variant, which might explain immune escape.

EBIOMEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients

Bilgin Osmanodja et al.

Summary: High mortality and impaired response to COVID-19 vaccinations are observed in kidney transplant recipients. Retrospective analysis shows that up to five doses of SARS-CoV-2 vaccine induce serological response in these patients, especially when mycophenolic acid (MPA) is paused.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Predictors of Serological Response to SARS-CoV-2 Vaccination in Kidney Transplant Patients: Baseline Characteristics, Immunosuppression, and the Role of IMPDH Monitoring

Lutz Liefeldt et al.

Summary: Immunosuppression increases the risk of severe COVID-19 in kidney transplant patients. The determinants of vaccination response were analyzed in this cohort study, revealing that longer time after transplantation, higher glomerular filtration rate, and younger age were associated with better response. Heterologous vaccination was more effective and the use of calcineurin inhibitors plus mycophenolate reduced seroconversion rate. Erythrocyte IMPDH activity was a better predictor of response than mycophenolate dose in mycophenolate-treated patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Medicine, Research & Experimental

Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients

Eva Schrezenmeier et al.

Summary: Transplant recipients may have impaired immunity after SARS-CoV-2 vaccination due to immunosuppression caused by mycophenolate (MPA). Temporary MPA hold has been shown to greatly improve the outcomes of booster vaccination in these patients.

JCI INSIGHT (2022)

Add to Collection

Article Medicine, General & Internal

Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination-A Non-randomized, Controlled Pilot Study

Florina Regele et al.

Summary: Kidney transplant recipients are at high risk of severe COVID-19, but their vaccine response is impaired, especially for those on triple immunosuppression. Pausing of mycophenolic acid (MPA) or azathioprine (AZA) for two weeks around vaccination did not increase seroconversion rate, but one third of non-responders developed antibodies after an additional dose, supporting continued vaccination.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Surgery

Immune response to third SARS-CoV-2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction

Marta Kantauskaite et al.

Summary: A reduction of >=33% in MMF dose before the third vaccination significantly increased the seroconversion rate in KTRs, according to propensity score matching analysis. Initial antibody levels, graft function, time after transplantation, and MMF trough levels also had an impact on seroconversion.

CLINICAL TRANSPLANTATION (2022)

Add to Collection

Article Medicine, General & Internal

Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid

Louise Benning et al.

Summary: This study found that additional COVID-19 vaccination significantly increased SARS-CoV-2 specific antibodies in kidney transplant recipients who did not show an immune response, especially during the withdrawal of mycophenolic acid.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

D. M. Weinreich et al.

Summary: Recent data indicate that complications and death from Covid-19 may be related to high viral loads. In this trial involving nonhospitalized patients, a cocktail of two neutralizing monoclonal antibodies (REGN-COV2) reduced viral load, with a greater effect in patients with no immune response or high viral load at baseline. Safety outcomes were similar between REGN-COV2 dose groups and the placebo group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Shuo Feng et al.

Summary: Defined levels of SARS-CoV-2-specific binding and neutralizing antibodies elicited by the COVID-19 vaccine were identified as correlates of protection against symptomatic infection. Higher levels of immune markers were correlated with a reduced risk of symptomatic infection. The data can be used to extrapolate efficacy estimates to new populations.

NATURE MEDICINE (2021)

Add to Collection

Editorial Material Urology & Nephrology

COVID-19 vaccination in kidney transplant recipients

Sophie Caillard et al.

Summary: Kidney transplant recipients, due to therapeutic immunosuppression, have impaired immune responses to the COVID-19 mRNA vaccine, necessitating a personalized intensified vaccination approach for better protection.

NATURE REVIEWS NEPHROLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

Ilies Benotmane et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Letter Urology & Nephrology

A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response

Christophe Masset et al.

KIDNEY INTERNATIONAL (2021)

Add to Collection

Article Health Care Sciences & Services

Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine

Julian Stumpf et al.

Summary: The study showed that dialysis patients had a high seroconversion rate after receiving the boost vaccination, while the majority of transplant recipients had impaired humoral responses. The type and number of immunosuppressive drugs, as well as the type of vaccine, were major determinants of seroconversion failure in both dialysis and transplant patients.

LANCET REGIONAL HEALTH-EUROPE (2021)

Add to Collection

Letter Medicine, General & Internal

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

Tomer Merison et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Urology & Nephrology

Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients

Thilo Kolb et al.

Summary: Patients with kidney failure, especially kidney transplant recipients, have weaker antibody responses to COVID-19 vaccines, with a majority of KTRs not developing neutralizing antibodies after vaccination. These findings suggest the need for modification of vaccination strategies in KTRs and patients on dialysis.

KIDNEY360 (2021)

Add to Collection

Review Health Care Sciences & Services

A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models

Evangelia Christodoulou et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement

Gary S. Collins et al.

ANNALS OF INTERNAL MEDICINE (2015)

Add to Collection

© Peeref 2019-2024. All rights reserved.